Company intelligence / Profile preview

Epineuron Technologies

Mississauga, Ontario, Canadaepineurontech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Epineuron’s PeriPulse™ system has demonstrated significant and sustained improvement in sensation for patients with peripheral nerve injuries, with 87.5% of treated patients showing clinically meaningful gains at six months post-injury in a first-in-human pilot study. The device is Health Canada approved, designated an FDA Breakthrough Device, and is being evaluated in the large REGAIN™ multinational clinical trial across Canada and the US to support further regulatory approvals. The system has shown high patient tolerance and safety.

Therapeutic areas: Neurology
Modalities: DeviceBioelectronic therapy
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

PeriPulse

Commercial

Indications: Peripheral nerve injury

Partnerships

Not explicitly listed; collaborations with major Canadian/US hospitals for clinical trials are implied.

Beyond the preview

Go deeper on Epineuron Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epineuron Technologies.

Explore the full profile